Effect of Duration of Disease on Gait Parameters in Parkinson’s Patients

Aygün Özşahin, Dilek Günal, Hülya Demir, Ayşe Akpınar, Ali Üçkardeş, Önder Us

Issue: 2007, Volume 13 - Issue 2
0 353

Transcranial Magnetic Stimulation in Idiopathic Parkinson’s Disease

Gülbin Yüksel, Geysu Karlıkkaya, Hülya Tireli

Issue: 2006, Volume 12 - Issue 2
0 420

Risk Factors in Developing Hallucinations in Parkinson’s Disease

Gülçin Benbir, Sibel Özekmekçi, Meral Çınar, Fuat Beşkardeş, Hülya Apaydın, Ethem Erginöz

Issue: 2006, Volume 12 - Issue 1
0 330

Cerrahpasa Faculty of Medicine Data Bank: The Evaluation of Motor Complications in 555 Parkinson's Patients on levodopa Therapy

Gülçin BENBİR, Sibel ÖZEKMEKÇİ, Hülya APAYDIN, Şakir DELİL, Ethem ERGİNÖZ

Issue: 2005, Volume 11 - Issue 6
0 226

Cerrahpaşa Faculty of Medicine Data Bank: The Demographic and Clinical Characteristics of 647 Parkinson Patients

Şakir DELİL, Gülçin BENBİR, Hülya APAYDIN, Sibel ÖZEKMEKÇİ, Ethem ERGİNÖZ

Issue: 2005, Volume 11 - Issue 5
0 346

Parkinsonism Due To Manganese Intoxication: Two Case Reports

Djumagyz DJAKSYBAEVA, Sibel ÖZEKMEKÇİ, Güneş KIZILTAN, İdris SAYILIR, Burç Çağrı POYRAZ

Issue: 2005, Volume 11 - Issue 1
0 291

Cigarette Smoking and Parkinson's Disease

Funda UYSAL TAN, M. Cenk AKBOSTANCI, Babür DORA, Başak BOLLUK, Adil ÇULCUOĞLU

Issue: 2004, Volume 10 - Issue 6
0 275

The Clinical Features of Parkinson 's Disease Relation to the Age at Onset

Meltem DEMİRKIRAN, Şebnem BIÇAKCI, Yakup SARICA

Issue: 2002, Volume 8 - Issue 1
0 223

The Use of Apomorphine in Parkinson 's Disease

Haşmet A. HANAĞASI, Gülüstü KAPTANOĞLU, Murat EMRE

Issue: 2001, Volume 7 - Issue 2
0 265

THE USE OF APOMORPHINE IN PARKINSON'S DISEASE

Haşmet A. HANAĞASI, Gülüstü KAPTANOĞLU, Murat EMRE

Issue: 2001, Volume 7 - Issue 1
0 269

Ablative surgery in Parkinson's Disease: A Long-Term Follow-up of 18 Patients

Sibel ERTAN, Hülya APAYDIN, Şakir DELİL, Sibel ÖZEKMEKÇİ, Orhan BARLAS

Issue: 2000, Volume 6 - Issue 1
0 237

Effect of General Anesthesia on the Emergence of Parkinson's Disease

M. Cenk AKBOSTANCI, Funda TAN, Sıla USAR, Hatice BALABAN, Nermin MUTLUER

Issue: 2000, Volume 6 - Issue 1
0 292

Middle Latency Somatosensory Evoked Potentials in Hemiparkinsonism

A. SOYSAL, F. ÖZER, B. ARPACI

Issue: 1999, Volume 5 - Issue 2
0 219

Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 258

Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 258

H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease

Ayhan ÖZTÜRK, Hilmi UYSAL

Issue: 1998, Volume 4 - Issue 3-4
0 284

New Developments in Parkinson's Disease Management

M. Cenk AKBOSTANCI

Issue: 1998, Volume 4 - Issue 1-2
0 235

P300 and P300 Topographic Mapping in Parkinson's Disease

Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU

Issue: 1995, Volume 1 - Issue 4
0 264

THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS

Bülent ELİBOL

Issue: 1995, Volume 1 - Issue 1
0 266

Scale consistance in cognitive status awareness of patients with Parkinson’s disease

Sabiha Tezcan Aydemir, Elif Yüsra Unutmaz, Pınar Özkan, Talha Abalı, Gülnur Ayık, Dudu Genç Batmaz, Sema Nur Kibrit, Ahmet Veli Karacan, Müge Kuzu Kumcu, Merve Koç Yekedüz, Fatma Tuba Eminoğlu, Rezzak Yılmaz, Muhittin Cenk Akbostancı

DOI: 10.55697/tnd.2024.139

Issue: 2024, Volume 30 - Issue 3
632 374